Jan 20, 2020
ZyVersa Therapeutics Releases Video Demonstrating How Inflammasomes Stimulate and Perpetuate Inflammation, and How a Novel Inflammasome Inhibitor, IC 100, Has Potential to Control Chronic Damaging Inflammation Associated with Inflammatory Diseases
Nov 14, 2019
Viscos, LLC Announces Issuance of U.S. Patent for Hyaluronan Composition Use for Mitigation and/or Prevention of Inflammation and/or Pain
Sep 12, 2019
ZyVersa Therapeutics' Perspectives on Inflammasomes Reported in BIOCENTURY Innovations Article
Apr 22, 2019
Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Novel Inflammasome Inhibitor
Jan 30, 2019
CardioVax Announces Name Change to Abcentra
Feb 27, 2018
Aldeyra Therapeutics Announces Agreement with Johnson & Johnson Innovation to Advance Novel Immune-Modulating Drugs for Systemic Inflammatory Diseases
Feb 15, 2018
Tremeau Completes $5.2 Million Equity Raise to Fund Non-Opioid Pain Treatments for Rare Diseases
Feb 05, 2018
GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More
Jan 18, 2018
Elanco Innovations Named Best Products for 2017
Oct 04, 2017
Study Shows Topical Analgesics Reduce Chronic Pain, Lessens Need For Opioids
Sep 19, 2017
Cardax Welcomes Cardiovascular Research Breakthrough
Jul 26, 2017
Complexa Raises $62 Million in Series C Financing to Test CXA-10 in Two Orphan Disease Proof-of-Concept Trials
Jun 19, 2017
Aldeyra Therapeutics to Present Novel Data on the Anti-Inflammatory Mechanism and Activity of ADX-102 at the World Congress on Inflammation 2017 Annual Meeting